Marpai Secures $700K Private Placement with Institutional & Insider Backing | MRAI Stock News
Summary
, Dec. 5, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a technology platform company, which operates as a national Third-Party Administrator (TPA) through its subsidiaries and is transforming the TPA market by offering affordable, intelligent, healthcare solutions to self-funded employer health plans, today announced the pricing of a private placement offering consisting of the issuance and sale of 621,194 shares of its Class A common stock (the "Common Stock"), par value per share, at a purchase price of per Common Stock, for aggregate gross proceeds of . Primarily competing in the TPA sector serving self-funded employer health plans representing over in annual claims. Operating nationwide, Marpai offers access to leading provider networks including Aetna and Cigna and all TPA services. Investors are invited to visit https://www.ir.marpaihealth.comThis press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect Marpais current expectations and speak only as of the date of this release.